FDA’s Brief To The Fifth Circuit in the AHM Case Is Worth A Read
Drug & Device Law
MAY 11, 2023
A perusal of amicus briefs drew more than a few “they should know what they are talking about here” responses to groups of food and drug law scholars (as opposed to DDL bloggers), former FDA commissioners, former FDA officials, and former DOJ officials, among others. The appellate brief from FDA bears that out well.
Let's personalize your content